624 related articles for article (PubMed ID: 10771483)
1. IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230.
Skaria M; Jaunin F; Hunziker T; Riou S; Schumann H; Bruckner-Tuderman L; Hertl M; Bernard P; Saurat JH; Favre B; Borradori L
J Invest Dermatol; 2000 May; 114(5):998-1004. PubMed ID: 10771483
[TBL] [Abstract][Full Text] [Related]
2. IgG autoantibodies from bullous pemphigoid (BP) patients bind antigenic sites on both the extracellular and the intracellular domains of the BP antigen 180.
Perriard J; Jaunin F; Favre B; Büdinger L; Hertl M; Saurat JH; Borradori L
J Invest Dermatol; 1999 Feb; 112(2):141-7. PubMed ID: 9989787
[TBL] [Abstract][Full Text] [Related]
3. IgG autoantibody reactivity against bullous pemphigoid (BP) 180 and BP230 in elderly patients with pruritic dermatoses.
Feliciani C; Caldarola G; Kneisel A; Podstawa E; Pfütze M; Pfützner W; Hertl M
Br J Dermatol; 2009 Aug; 161(2):306-12. PubMed ID: 19485996
[TBL] [Abstract][Full Text] [Related]
4. Autoreactive T and B cells from bullous pemphigoid (BP) patients recognize epitopes clustered in distinct regions of BP180 and BP230.
Thoma-Uszynski S; Uter W; Schwietzke S; Schuler G; Borradori L; Hertl M
J Immunol; 2006 Feb; 176(3):2015-23. PubMed ID: 16424234
[TBL] [Abstract][Full Text] [Related]
5. Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain.
Hofmann S; Thoma-Uszynski S; Hunziker T; Bernard P; Koebnick C; Stauber A; Schuler G; Borradori L; Hertl M
J Invest Dermatol; 2002 Nov; 119(5):1065-73. PubMed ID: 12445194
[TBL] [Abstract][Full Text] [Related]
6. IgA autoantibodies in the pemphigoids and linear IgA bullous dermatosis.
Horváth B; Niedermeier A; Podstawa E; Müller R; Hunzelmann N; Kárpáti S; Hertl M
Exp Dermatol; 2010 Jul; 19(7):648-53. PubMed ID: 20500772
[TBL] [Abstract][Full Text] [Related]
7. Role of BP230 autoantibodies in bullous pemphigoid.
Shih YC; Wang B; Yuan H; Zheng J; Pan M
J Dermatol; 2020 Apr; 47(4):317-326. PubMed ID: 32048350
[TBL] [Abstract][Full Text] [Related]
8. IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice.
Feldrihan V; Licarete E; Florea F; Cristea V; Popescu O; Sitaru C; Chiriac MT
Hum Immunol; 2014 Apr; 75(4):354-63. PubMed ID: 24468586
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid.
Ishiura N; Fujimoto M; Watanabe R; Nakashima H; Kuwano Y; Yazawa N; Echigo T; Okochi H; Tamaki K
J Dermatol Sci; 2008 Feb; 49(2):153-61. PubMed ID: 17920818
[TBL] [Abstract][Full Text] [Related]
10. IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity.
Döpp R; Schmidt E; Chimanovitch I; Leverkus M; Bröcker EB; Zillikens D
J Am Acad Dermatol; 2000 Apr; 42(4):577-83. PubMed ID: 10727301
[TBL] [Abstract][Full Text] [Related]
11. IgG autoantibodies from a lichen planus pemphigoides patient recognize the NC16A domain of the bullous pemphigoid antigen 180.
Skaria M; Salomon D; Jaunin F; Friedli A; Saurat JH; Borradori L
Dermatology; 1999; 199(3):253-5. PubMed ID: 10592407
[TBL] [Abstract][Full Text] [Related]
12. Preferential Reactivity of Dipeptidyl Peptidase-IV Inhibitor-Associated Bullous Pemphigoid Autoantibodies to the Processed Extracellular Domains of BP180.
Mai Y; Nishie W; Izumi K; Shimizu H
Front Immunol; 2019; 10():1224. PubMed ID: 31191560
[TBL] [Abstract][Full Text] [Related]
13. Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain.
Giudice GJ; Emery DJ; Zelickson BD; Anhalt GJ; Liu Z; Diaz LA
J Immunol; 1993 Nov; 151(10):5742-50. PubMed ID: 8228259
[TBL] [Abstract][Full Text] [Related]
14. IgE antibodies in sera from patients with bullous pemphigoid are autoantibodies preferentially directed against the 230-kDa epidermal antigen (BP230).
Ghohestani RF; Cozzani E; Delaporte E; Nicolas JF; Parodi A; Claudy A
J Clin Immunol; 1998 May; 18(3):202-9. PubMed ID: 9624579
[TBL] [Abstract][Full Text] [Related]
15. Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid.
Di Zenzo G; Thoma-Uszynski S; Fontao L; Calabresi V; Hofmann SC; Hellmark T; Sebbag N; Pedicelli C; Sera F; Lacour JP; Wieslander J; Bruckner-Tuderman L; Borradori L; Zambruno G; Hertl M
Clin Immunol; 2008 Sep; 128(3):415-26. PubMed ID: 18571472
[TBL] [Abstract][Full Text] [Related]
16. Bullous pemphigoid sera react specifically with various domains of BP230, most frequently with C-terminal domain, by immunoblot analyses using bacterial recombinant proteins covering the entire molecule.
Hamada T; Nagata Y; Tomita M; Salmhofer W; Hashimoto T
Exp Dermatol; 2001 Aug; 10(4):256-63. PubMed ID: 11493314
[TBL] [Abstract][Full Text] [Related]
17. Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180.
Schmidt E; Skrobek C; Kromminga A; Hashimoto T; Messer G; Bröcker EB; Yancey KB; Zillikens D
Br J Dermatol; 2001 Nov; 145(5):778-83. PubMed ID: 11736901
[TBL] [Abstract][Full Text] [Related]
18. Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity.
Oyama N; Setterfield JF; Powell AM; Sakuma-Oyama Y; Albert S; Bhogal BS; Vaughan RW; Kaneko F; Challacombe SJ; Black MM
Br J Dermatol; 2006 Jan; 154(1):90-8. PubMed ID: 16403100
[TBL] [Abstract][Full Text] [Related]
19. Plectin, an unusual target antigen in bullous pemphigoid.
Laffitte E; Favre B; Fontao L; Riou S; Jaunin F; Tamm K; Saurat JH; Borradori L
Br J Dermatol; 2001 Jan; 144(1):136-8. PubMed ID: 11167694
[TBL] [Abstract][Full Text] [Related]
20. Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid.
Verraes S; Hornebeck W; Polette M; Borradori L; Bernard P
J Invest Dermatol; 2001 Nov; 117(5):1091-6. PubMed ID: 11710917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]